Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.
作者信息
Zeng Guangting
机构信息
The First People's Hospital of Chenzhou, University of South China, Chenzhou 423000, China.
出版信息
Lancet Microbe. 2022 Aug;3(8):e561. doi: 10.1016/S2666-5247(22)00150-1. Epub 2022 May 31.
Abstract
摘要
相似文献
1
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.SARS-CoV-2 ARCoV mRNA疫苗的安全性和免疫原性。
Lancet Microbe. 2022 Aug;3(8):e561. doi: 10.1016/S2666-5247(22)00150-1. Epub 2022 May 31.
2
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性：一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
3
Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.新冠病毒mRNA疫苗在信号转导和转录激活因子1功能获得性患者中的免疫原性和安全性
J Clin Immunol. 2022 Feb;42(2):266-269. doi: 10.1007/s10875-021-01163-8. Epub 2021 Oct 31.
4
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.信使核糖核酸新冠疫苗接种后心肌炎风险的Meta分析
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
5
Safety of mRNA-Based Vaccines for SARS CoV-2.mRNA 疫苗在 SARS-CoV-2 中的安全性。
Chem Res Toxicol. 2021 Aug 16;34(8):1823-1825. doi: 10.1021/acs.chemrestox.1c00129. Epub 2021 May 19.
6
COVID-19 vaccination in Israel.以色列的新冠疫苗接种情况。
Clin Microbiol Infect. 2021 Nov;27(11):1570-1574. doi: 10.1016/j.cmi.2021.07.041. Epub 2021 Aug 9.
7
Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan.新型冠状病毒mRNA疫苗引发的获得性甲型血友病：巴基斯坦首例病例。
Scand J Clin Lab Invest. 2022 Sep;82(5):432-434. doi: 10.1080/00365513.2022.2092902. Epub 2022 Jun 29.
8
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.既往感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会增加接种SARS-CoV-2信使核糖核酸（mRNA）疫苗后的反应原性，并可能根据感染时间延迟疫苗接种。
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
9
10
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates.靶向 RBD 的 COVID-19 mRNA 疫苗在非人灵长类动物中的长期稳定性和保护效力。
Signal Transduct Target Ther. 2021 Dec 24;6(1):438. doi: 10.1038/s41392-021-00861-4.
引用本文的文献
1
How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development.mRNA 药物的新浪潮离我们还有多远？mRNA 产品的现状和未来发展。
Front Immunol. 2022 Sep 12;13:974433. doi: 10.3389/fimmu.2022.974433. eCollection 2022.
Zotero 插件